Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415205955> ?p ?o ?g. }
- W2415205955 endingPage "89" @default.
- W2415205955 startingPage "73" @default.
- W2415205955 abstract "The histone deacetylase (HDAC) inhibitors have been demonstrated as an emerging class of anticancer drugs. HDACs are involved in regulation of gene expression and in chromatin remodeling, thus indicating valid targets for different types of cancer therapeutics. The pan-deacetylase inhibitor panobinostat (Farydac®, LBH589) was developed by Novartis Pharmaceuticals and has been recently approved by the US Food and Drug Administraion (FDA) as a drug to treat multiple myeloma. It is under clinical investigation for a range of haematological and solid tumors worldwide in both oral and intravenous formulations. Panobinostat inhibits tumor cell growth by interacting with acetylation of histones and non-histone proteins as well as various apoptotic, autophagy-mediated targets and various tumorogenesis pathways involved in development of tumors. The optimal combination regimen for pancreatic cancer remains to be fully elucidated with various combination regimens, and should be investigated in clinical trials. This article summarizes the current preclinical and clinical status of panobinostat in pancreatic cancer. Preclinical data suggests that panobinostat has potential inhibitory activity in pancreatic cancer cells by targeting various pathways and factors involved in the development of cancer. Herein, we reviewed the status of mono and combination therapy and the rationale behind the combination therapy undergoing trials, as well as possible future prospective use in the treatment of pancreatic cancer." @default.
- W2415205955 created "2016-06-24" @default.
- W2415205955 creator A5026353590 @default.
- W2415205955 creator A5031730635 @default.
- W2415205955 creator A5037611386 @default.
- W2415205955 creator A5054433339 @default.
- W2415205955 creator A5064632473 @default.
- W2415205955 date "2016-06-01" @default.
- W2415205955 modified "2023-10-15" @default.
- W2415205955 title "Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects" @default.
- W2415205955 cites W1551067897 @default.
- W2415205955 cites W1556190571 @default.
- W2415205955 cites W1934530049 @default.
- W2415205955 cites W1967018540 @default.
- W2415205955 cites W1968356004 @default.
- W2415205955 cites W1968938690 @default.
- W2415205955 cites W1970720114 @default.
- W2415205955 cites W1971691280 @default.
- W2415205955 cites W1976284083 @default.
- W2415205955 cites W1977261522 @default.
- W2415205955 cites W1980220720 @default.
- W2415205955 cites W1983770251 @default.
- W2415205955 cites W1986410613 @default.
- W2415205955 cites W1989429100 @default.
- W2415205955 cites W1989696433 @default.
- W2415205955 cites W1990801507 @default.
- W2415205955 cites W1990824742 @default.
- W2415205955 cites W1991660464 @default.
- W2415205955 cites W1992499848 @default.
- W2415205955 cites W1992884105 @default.
- W2415205955 cites W1996809397 @default.
- W2415205955 cites W1997545280 @default.
- W2415205955 cites W2000461686 @default.
- W2415205955 cites W2006080792 @default.
- W2415205955 cites W2006172084 @default.
- W2415205955 cites W2010028880 @default.
- W2415205955 cites W2011660168 @default.
- W2415205955 cites W2015645056 @default.
- W2415205955 cites W2020736126 @default.
- W2415205955 cites W2020928902 @default.
- W2415205955 cites W2025329569 @default.
- W2415205955 cites W2025909040 @default.
- W2415205955 cites W2027303416 @default.
- W2415205955 cites W2028985159 @default.
- W2415205955 cites W2032395096 @default.
- W2415205955 cites W2035987476 @default.
- W2415205955 cites W2042647692 @default.
- W2415205955 cites W2046577405 @default.
- W2415205955 cites W2047123719 @default.
- W2415205955 cites W2049693797 @default.
- W2415205955 cites W2049957499 @default.
- W2415205955 cites W2050057972 @default.
- W2415205955 cites W2051406215 @default.
- W2415205955 cites W2055130200 @default.
- W2415205955 cites W2067085353 @default.
- W2415205955 cites W2069151706 @default.
- W2415205955 cites W2072278069 @default.
- W2415205955 cites W2072375732 @default.
- W2415205955 cites W2077108721 @default.
- W2415205955 cites W2078211225 @default.
- W2415205955 cites W2079489832 @default.
- W2415205955 cites W2080188178 @default.
- W2415205955 cites W2081065930 @default.
- W2415205955 cites W2085512717 @default.
- W2415205955 cites W2086338128 @default.
- W2415205955 cites W2088094723 @default.
- W2415205955 cites W2089179463 @default.
- W2415205955 cites W2091151146 @default.
- W2415205955 cites W2097829773 @default.
- W2415205955 cites W2100751052 @default.
- W2415205955 cites W2103456217 @default.
- W2415205955 cites W2104337841 @default.
- W2415205955 cites W2109098380 @default.
- W2415205955 cites W2114468318 @default.
- W2415205955 cites W2117489053 @default.
- W2415205955 cites W2124408864 @default.
- W2415205955 cites W2124603636 @default.
- W2415205955 cites W2132682917 @default.
- W2415205955 cites W2132880072 @default.
- W2415205955 cites W2132983060 @default.
- W2415205955 cites W2140504081 @default.
- W2415205955 cites W2141542227 @default.
- W2415205955 cites W2142233318 @default.
- W2415205955 cites W2145470144 @default.
- W2415205955 cites W2146816088 @default.
- W2415205955 cites W2147678069 @default.
- W2415205955 cites W2148345668 @default.
- W2415205955 cites W2148656635 @default.
- W2415205955 cites W2151445954 @default.
- W2415205955 cites W2156089236 @default.
- W2415205955 cites W2158013970 @default.
- W2415205955 cites W2164453551 @default.
- W2415205955 cites W2169508075 @default.
- W2415205955 cites W2258225306 @default.
- W2415205955 cites W2326619066 @default.
- W2415205955 cites W2326718372 @default.
- W2415205955 cites W2567356540 @default.
- W2415205955 cites W3140139122 @default.